Islatravir
Records for this ingredient, by country (identity only).
ATC — · 3 markets · 3 records
US 1 records · 1 shown of 1
Combination products containing this ingredient
- 0.25 mgtablet CombinationDoravirine 100 mg + Islatravir 0.25 mgIDVYNSO
CA 1 records · 1 shown of 1
Combination products containing this ingredient
- 0.25 mgtablet CombinationDoravirine 100 mg + Islatravir 0.25 mgIDVYNSO
JP 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名イドビンソ配合錠 ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | CA | JP |
|---|---|---|---|
| 0.25 mg Combination Doravirine 100 mg + Islatravir 0.25 mg tablet | IDVYNSO | IDVYNSO | |
| Combination Doravirine + Islatravir tablet | イドビンソ配合錠 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.